Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Research and development expenses		$ 776	$ 461
General and administrative expenses		853	245
Operating loss		1,629	706
Total financial expense, net		(4)	12
Net loss and comprehensive loss		$ 1,625	$ 718
Basic and diluted net loss per share (in Dollars per share)		$ 0.15	$ 0.07
Weighted average number of common shares used in computing basic and diluted net loss per share (in Shares)	[1]	11,171,704	9,459,253

[1] Number of shares has been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the reverse recapitalization transaction and to reflect adjustment to the share par value (refer to Note 1a).